Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 16,801-16,812 of 23,847
Drug study icon
CompletedNCT01778244

Metformin for Treatment of Antipsychotic-induced Dyslipidemia

This summary needs review. Please check the official study record and contact the research team for details.

In Changsha
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Drug study icon
TerminatedNCT01177709

Metformin for Weight Loss in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In New York
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
CompletedNCT05838573

Metformin Treatment on Cognitive Impairment of Schizophrenia

This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

Multiple locations, including Changsha
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
China
Sponsor
Central South University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT00378079

Methadone Maintenance for Prisoners

This summary needs review. Please check the official study record and contact the research team for details.

In Baltimore
AddictionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Friends Research Institute, Inc.
Condition
Addiction
Other study type icon
CompletedNCT01191242

Methadone Monitoring for Insights Into Adverse Events

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Murray
AddictionOtherOver 18 Years
Countries
United States
Sponsor
Intermountain Health Care, Inc.
Condition
Addiction
Behavioral study icon
CompletedNCT03416504

Methods for Managing Intrusive Thoughts

This summary needs review. Please check the official study record and contact the research team for details.

In Chapel Hill
OCDBehavioralOver 18 Years
Countries
United States
Sponsor
University of North Carolina, Chapel Hill
Condition
OCD
Drug study icon
CompletedNCT00214877

Methylene Blue for Cognitive Dysfunction in Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Halifax
BipolarityDrugFrom 18 Years to 65 Years
Countries
Canada
Sponsor
Nova Scotia Health Authority
Condition
Bipolarity
Drug study icon
CompletedNCT00015054

Methylphendidate Treatment of Cocaine Dependent people with Attention Deficit Hyperactivity Disorder - 3

This study exists to see whether a therapy or guided support program is workable and worth testing more broadly. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In Cincinnati
ADHDDrugFrom 21 Years to 50 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.